Acute Respiratory Distress Syndrome clinical trials

Explore recruiting acute respiratory distress syndrome clinical trials.

Recruiting acute respiratory distress syndrome studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Respiratory Distress Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy of intravenous metoprolol in patients with Acute Respiratory Distress Syndrome (ARDS).

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Potential of FX06 to improve disease severity in Acute Respiratory Distress Syndrome patients (Ixion 2.0)

Spain, France, Romania, Germany, Lithuania

Therapeutic exploratory (Phase II) EU CTIS Study details

APROTININ TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME: A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III TRIAL

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Impact of post-Acute respiratory distress syndrome COVID sedation on late neuroinflammation (PET-DEXDOCOVID)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase 2, proof-of-concept, randomized, double-blinded, placebo-controlled, multicenter study to assess efficacy and safety of reparixin as add-on therapy to standard of care in adult patients with Acute Respiratory Distress Syndrome (RESPIRATIO)

Italy, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomized Clinical Trial of Inhaled Sedation with Sevoflurane in Critically Ill Patients at Risk of Developing the Acute Respiratory Distress Syndrome

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Acute Respiratory Distress Syndrome trials by city

Acute Respiratory Distress Syndrome in Toronto Acute Respiratory Distress Syndrome in Vancouver Acute Respiratory Distress Syndrome in Montreal Acute Respiratory Distress Syndrome in Calgary Acute Respiratory Distress Syndrome in Edmonton Acute Respiratory Distress Syndrome in Ottawa Acute Respiratory Distress Syndrome in Winnipeg Acute Respiratory Distress Syndrome in Quebec City Acute Respiratory Distress Syndrome in Hamilton Acute Respiratory Distress Syndrome in Kitchener Acute Respiratory Distress Syndrome in London Acute Respiratory Distress Syndrome in Halifax Acute Respiratory Distress Syndrome in New York Acute Respiratory Distress Syndrome in Los Angeles Acute Respiratory Distress Syndrome in Chicago Acute Respiratory Distress Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease